Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
-
* Corresponding author: Sandro Pignata sandro.pignata@fondazionepascale.it
BMC Cancer 2006, 6:5 doi:10.1186/1471-2407-6-5
Accesses
- Last 30 days: 102 accesses
- Last 365 days: 866 accesses
- All time: 5045 accesses